1.Prenatal diagnosis of a novel SOX10 mutation in a patient with syndromic hearing loss.
Chiyan ZHOU ; Xiaodan LIU ; Qinhao SONG ; Suping LI ; Shaoping ZHONG ; Huaxiang SHEN
Chinese Journal of Medical Genetics 2019;36(5):477-479
OBJECTIVE:
To explore the genetic basis for a patient with syndromic hearing loss.
METHODS:
Genomic DNA of the patient was extracted, for which 127 deafness-related genes were enriched with a chip. Following next generation sequencing, pathogenic loci in exonic regions were analyzed through comparison against the databases. Genotype of her fetus for the suspected site was determined by testing the amniotic fluid sample. qPCR method was applied to verify the deletion of a large fragment.
RESULTS:
The proband was diagnosed with Waardenburg syndrome type 2, and had harbored a novel heterozygous deletion of the exons 3 and 4 of the SOX10 gene. Her fetus was found to carry the same deletion and presented with blue eyes and deafness after birth.
CONCLUSION
Waardenburg syndrome type 2 due to SOX10 gene deletion may feature autosomal dominant inheritance with incomplete penetrance. The deletion of exons 3 and 4 of the SOX10 gene probably underlies the disease in this family.
Eye Color
;
Female
;
Hearing Loss
;
Humans
;
Mutation
;
Pedigree
;
Pregnancy
;
Prenatal Diagnosis
;
SOXE Transcription Factors
;
genetics
;
Waardenburg Syndrome
2.Analysis of clinical phenotype and genetic variants among four Chinese pedigrees affected with Waardenburg syndrome.
Lulu WANG ; Lu MAO ; Hongen XU ; Shuping SUN ; Bin ZUO ; Wei LU
Chinese Journal of Medical Genetics 2023;40(6):661-667
OBJECTIVE:
To explore the genetic basis for four Chinese pedigrees affected with Waardenburg syndrome (WS).
METHODS:
Four WS probands and their pedigree members who had presented at the First Affiliated Hospital of Zhengzhou University between July 2021 and March 2022 were selected as the study subjects. Proband 1, a 2-year-and-11-month female, had blurred speech for over 2 years. Proband 2, a 10-year-old female, had bilateral hearing loss for 8 years. Proband 3, a 28-year-old male, had right side hearing loss for over 10 years. Proband 4, a 2-year-old male, had left side hearing loss for one year. Clinical data of the four probands and their pedigree members were collected, and auxiliary examinations were carried out. Genomic DNA was extracted from peripheral blood samples and subjected to whole exome sequencing. Candidate variants were verified by Sanger sequencing.
RESULTS:
Proband 1, with profound bilateral sensorineural hearing loss, blue iris and dystopia canthorum, was found to have harbored a heterozygous c.667C>T (p.Arg223Ter) nonsense variant of the PAX3 gene, which was inherited from her father. Based on the guidelines from the American College of Medical Genetics and Genomics (ACMG), the variant was classified as pathogenic (PVS1+PM2_Supporting+PP4), and the proband was diagnosed with WS type I. Proband 2, with moderate sensorineural hearing loss on the right side and severe sensorineural hearing loss on the left side, has harbored a heterozygous frameshifting c.1018_1022del (p.Val340SerfsTer60) variant of the SOX10 gene. Neither of her parents has harbored the same variant. Based on the ACMG guidelines, it was classified as pathogenic (PVS1+PM2_Supporting+PP4+PM6), and the proband was diagnosed with WS type II. Proband 3, with profound sensorineural hearing loss on the right side, has harbored a heterozygous c.23delC (p.Ser8TrpfsTer5) frameshifting variant of the SOX10 gene. Based on the ACMG guidelines, it was classified as pathogenic (PVS1+PM2_Supporting+PP4), and the proband was diagnosed with WS type II. Proband 4, with profound sensorineural hearing loss on the left side, has harbored a heterozygous c.7G>T (p.Glu3Ter) nonsense variant of the MITF gene which was inherited from his mother. Based on the ACMG guidelines, the variant was classified as pathogenic (PVS1+PM2_Supporting+PP4), and the proband was diagnosed with WS type II.
CONCLUSION
By genetic testing, the four probands were all diagnosed with WS. Above finding has facilitated molecular diagnosis and genetic counseling for their pedigrees.
Female
;
Humans
;
Male
;
Deafness
;
East Asian People
;
Hearing Loss, Sensorineural/genetics*
;
Mutation
;
Pedigree
;
Phenotype
;
Waardenburg Syndrome/diagnosis*
3.Genetic testing and prenatal diagnosis for a Chinese pedigree affected with Waardenburg syndrome type 4C due to heterozygous deletion of SOX10 gene.
Jingjing LI ; Hongfei KANG ; Xiangdong KONG
Chinese Journal of Medical Genetics 2023;40(11):1367-1372
OBJECTIVE:
To explore the genetic basis for a Chinese pedigree featuring congenital profound syndromic deafness and chronic constipation, and provide prenatal diagnosis for a high-risk fetus.
METHODS:
Whole-exome sequencing was carried out to analyze the sequences of genes associated with hereditary deafness, and multiplex ligation-dependent probe amplification (MLPA) was used to verify the candidate variant in the proband's parents and the fetus.
RESULTS:
The proband was found to have harbored a heterozygous deletion of SOX10, a pathogenic gene associated with Waardenburg syndrome type 4C (WS4C). The same deletion was found in her mother (with profound syndromic deafness and chronic constipation) and the fetus, but not in her father with normal hearing. Based on the guidelines from the American College of Medical Genetics and Genomics (ACMG) and Association for Molecular Pathology (AMP), the SOX10 gene deletion was predicted to be a pathogenic variant (PVS1+PM2_Supporting+PP1+PP4).
CONCLUSION
The pedigree was diagnosed with WS4C, which has conformed to an autosomal dominant inheritance. Deletion of the entire SOX10 gene, as a loss-of-function variant, probably underlay its pathogenesis. Above finding has facilitated genetic counseling and prenatal diagnosis for this family.
Humans
;
Female
;
Pregnancy
;
Pedigree
;
Waardenburg Syndrome/genetics*
;
East Asian People
;
Genetic Testing
;
Prenatal Diagnosis
;
Hearing Loss, Sensorineural/genetics*
;
Deafness/genetics*
;
Mothers
;
Constipation/genetics*
;
Mutation
;
SOXE Transcription Factors/genetics*
4.Identification of a Novel De Novo Variant in the PAX3 Gene in Waardenburg Syndrome by Diagnostic Exome Sequencing: The First Molecular Diagnosis in Korea.
Mi Ae JANG ; Taeheon LEE ; Junnam LEE ; Eun Hae CHO ; Chang Seok KI
Annals of Laboratory Medicine 2015;35(3):362-365
Waardenburg syndrome (WS) is a clinically and genetically heterogeneous hereditary auditory pigmentary disorder characterized by congenital sensorineural hearing loss and iris discoloration. Many genes have been linked to WS, including PAX3, MITF, SNAI2, EDNRB, EDN3, and SOX10, and many additional genes have been associated with disorders with phenotypic overlap with WS. To screen all possible genes associated with WS and congenital deafness simultaneously, we performed diagnostic exome sequencing (DES) in a male patient with clinical features consistent with WS. Using DES, we identified a novel missense variant (c.220C>G; p.Arg74Gly) in exon 2 of the PAX3 gene in the patient. Further analysis by Sanger sequencing of the patient and his parents revealed a de novo occurrence of the variant. Our findings show that DES can be a useful tool for the identification of pathogenic gene variants in WS patients and for differentiation between WS and similar disorders. To the best of our knowledge, this is the first report of genetically confirmed WS in Korea.
Adult
;
Amino Acid Sequence
;
Asian Continental Ancestry Group/genetics
;
Base Sequence
;
DNA/chemistry/genetics/metabolism
;
Exons
;
Humans
;
Male
;
Mutation, Missense
;
PAX3 Transcription Factor/*genetics
;
Phenotype
;
Polymorphism, Single Nucleotide
;
Republic of Korea
;
Sequence Analysis, DNA
;
Waardenburg Syndrome/*diagnosis/genetics
5.Clinical classification and genetic mutation study of two pedigrees with type II Waardenburg syndrome.
Yong CHEN ; Fuwei YANG ; Hexin ZHENG ; Ganghua ZHU ; Peng HU ; Weijing WU
Chinese Journal of Medical Genetics 2015;32(6):810-813
OBJECTIVETo explore the molecular etiology of two pedigrees affected with type II Waardenburg syndrome (WS2) and to provide genetic diagnosis and counseling.
METHODSBlood samples were collected from the proband and his family members. Following extraction of genomic DNA, the coding sequences of PAX3, MITF, SOX10 and SNAI2 genes were amplified with PCR and subjected to DNA sequencing to detect potential mutations.
RESULTSA heterozygous deletional mutation c.649_651delAGA in exon 7 of the MITF gene has been identified in all patients from the first family, while no mutation was found in the other WS2 related genes including PAX3, MITF, SOX10 and SNAI2.
CONCLUSIONThe heterozygous deletion mutation c.649_651delAGA in exon 7 of the MITF gene probably underlies the disease in the first family. It is expected that other genes may also underlie WS2.
Base Sequence ; DNA Mutational Analysis ; Exons ; genetics ; Family Health ; Female ; Genetic Predisposition to Disease ; genetics ; Heterozygote ; Humans ; Male ; Microphthalmia-Associated Transcription Factor ; genetics ; Molecular Sequence Data ; Mutation ; PAX3 Transcription Factor ; Paired Box Transcription Factors ; genetics ; Pedigree ; Polymerase Chain Reaction ; SOXE Transcription Factors ; genetics ; Sequence Deletion ; Snail Family Transcription Factors ; Transcription Factors ; genetics ; Waardenburg Syndrome ; classification ; diagnosis ; genetics
6.Analysis of nuclear localization and signal function of MITF protein predisposing to Warrdenburg syndrome.
Hua ZHANG ; Juan FENG ; Hongsheng CHEN ; Jiada LI ; Hunjin LUO ; Yong FENG
Chinese Journal of Medical Genetics 2015;32(6):805-809
OBJECTIVETo study the role of dysfunction of nuclear localization signals (NLS) of MITF protein in the pathogenesis of Waardenburg syndrome.
METHODSEukaryotic expression plasmid pCMV-MITF-Flag was used as a template to generate mutant plasmid pCMV-MITF△NLS-Flag by molecular cloning technique in order to design the mutagenic primers. The UACC903 cells were transfected transiently with MITF and MITF△NLS plasmids, and the luciferase activity assays were performed to determine their impact on the transcriptional activities of target gene tyrosinase (TYR). The oligonucleotide 5'-GAACGAAGAAGAAGATTT-3' was subcloned into pEGFP-N1 to generate recombinant eukaryotic expression plasmid pEGFP-N1-MITF-NLS. The NIH3T3 cells were transfected separately with MITF, MITF△NLS, pEGFP-N1 and pEGFP-N1-NLS plasmids, and their subcellular distribution was observed by immunoflorescence assays.
RESULTSExpression plasmids for the mutant MITF△NLS with loss of core NLS sequence and pEGFP-N1-NLS coupled with MITF△NLS were successfully generated. Compared with the wild-type MITF, MITF△NLS was not able to transactivate the transcriptional activities of promoter TYR and did not affect the normal function of MITF. MITF△NLS was only localized in the cytoplasm and pEGFP-N1 was found in both the cytoplasm and nucleus, whereas pEGFP-N1-NLS was mainly located in the nucleus.
CONCLUSIONThis study has confirmed the localization function of NLS sequence 213ERRRRF218 within the MITF protein. Mutant MITF with loss of NLS has failed to transactivate the transcriptional activities of target gene TYR, which can result in melanocyte defects and cause WS.
Amino Acid Sequence ; Animals ; Cell Line, Tumor ; Genetic Predisposition to Disease ; genetics ; Green Fluorescent Proteins ; genetics ; metabolism ; Humans ; Luciferases ; genetics ; metabolism ; Mice ; Microphthalmia-Associated Transcription Factor ; genetics ; metabolism ; Microscopy, Confocal ; Monophenol Monooxygenase ; genetics ; metabolism ; Mutation ; NIH 3T3 Cells ; Nuclear Localization Signals ; genetics ; Transcriptional Activation ; Transfection ; Waardenburg Syndrome ; diagnosis ; genetics ; metabolism